Savara announces new employment inducement grant under nasdaq listing rule 5635(c)(4)

Austin, texas--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the grant of an employee inducement award. on march 14, 2022, the compensation committee of savara's board of directors granted the inducement award to a new employee who recently joined the company. the inducement award consists of options to purchase 40,000 shares of the company's common stock. this equity award was granted under the sava
SVRA Ratings Summary
SVRA Quant Ranking